About Carbon Medical Technologies
Carbon Medical Technologies is a Healthcare company based in Saint Paul (United States) founded in 1994. Carbon-coated implantable devices for medical augmentation are manufactured. Carbon Medical Technologies offers products and services including BiomarC Fiducial Marker, BiomarC Tissue Marker, Durasphere Injectable Bulking Agent, and BiomarC Restore Lumpectomy Fiducial Marker. Its focus areas include Life Sciences, Gastroenterology, Medical Devices and Therapeutic Devices. Its legal entity is CARBON MEDICAL TECHNOLOGIES IN. Similar companies include EndoGastric Solutions, EndoChoice and CoapTech; 3 of its 3 listed similar companies have raised funding.
Company details
Carbon Medical Technologies develops, manufactures and markets carbon-coated implantable medical devices for soft tissue augmentation, tissue marking, and for vascular and neurological disorders. Its product offering includes: BiomarC Tissue Marker, for radiographical marking of soft tissue at a surgical site; series of injectable bulking agent composed of pyrolytic carbon coated beads suspended in a water-based carrier gel - Durasphere GR to treat problems associated with Gastroesophageal Reflux Disease (GERD) - Durasphere FI to treat problems associated with Fecal Incontinence in adult men and women, and - Durasphere EXP for the treatment of adult women with Stress Urinary Incontinence due to Intrinsic Sphinteric Deficiency.
- Headquarters Saint Paul, United States
- SectorsHealthcare
- Website carbonmed.com
- Social LinkedIn X Facebook YouTube
- Legal Name Carbon Medical Technologies In
Products & Services of Carbon Medical Technologies
Carbon Medical Technologies offers a comprehensive portfolio of products and services, including BiomarC Fiducial Marker, BiomarC Tissue Marker, Durasphere Injectable Bulking Agent, and BiomarC Restore Lumpectomy Fiducial Marker.
Enhances accuracy for radiation therapy procedures.
Used for marking breast tissue during biopsies.
Treats stress urinary incontinence in adult women.
Supports lumpectomy procedures with precise marking.
Apps and channels of Carbon Medical Technologies
its YouTube channel Carbon Med has 4 subscribers and 6 videos.
Videos from Carbon Medical Technologies
The most watched videos on Carbon Medical Technologies's YouTube channel, Carbon Med (4 subscribers). Click a video to play it here.
More on Carbon Med.
Similar companies to Carbon Medical Technologies
Carbon Medical Technologies has 3 listed similar companies in our database, 3 of them funded. They include EndoGastric Solutions, EndoChoice and CoapTech.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endogastricsolutions.com | 2002 | San Mateo, United States | $355.2M | 80 | Incisionless transoral procedures for upper GI diseases are developed. | |
| endochoice.com | 2008 | Alpharetta, United States | $115.96M | 414 | Devices, systems, and services are provided for GI specialists. | |
| coaptech.com | 2016 | Baltimore, United States | $16.52M | Minimally invasive gastrostomy feeding tube placement method is developed. |
Detailed similar companies of Carbon Medical Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Carbon Medical Technologies
The website of Carbon Medical Technologies (carbonmed.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 55.7% vs previous month
Websites whose visitors overlap most with Carbon Medical Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| theragenics.com | 100% | 1.9K | #8,782,610 | View details | |
| izimed.com | 88% | 3.8K | #5,149,944 | View details |
Top companies in Gastroenterology
3 companies that operate in the same segment as Carbon Medical Technologies (Gastroenterology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | 411 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Carbon Medical Technologies
Complete news archive for Carbon Medical Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Carbon Medical Technologies
Carbon Medical Technologies was founded in 1994.
Carbon Medical Technologies is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.
Carbon Medical Technologies develops, manufactures and markets carbon-coated implantable medical devices for soft tissue augmentation, tissue marking, and for vascular and neurological disorders. Its product offering includes: BiomarC Tissue Marker, for radiographical marking of soft tissue at a surgical site; series of injectable bulking agent composed of pyrolytic carbon coated beads suspended in a water-based carrier gel - Durasphere GR to treat problems associated with Gastroesophageal Reflux Disease (GERD) - Durasphere FI to treat problems associated with Fecal Incontinence in adult men and women, and - Durasphere EXP for the treatment of adult women with Stress Urinary Incontinence due to Intrinsic Sphinteric Deficiency.
Carbon Medical Technologies's top competitors include CoapTech, EndoChoice and EndoGastric Solutions.
Carbon Medical Technologies offers BiomarC Fiducial Marker, BiomarC Tissue Marker, Durasphere Injectable Bulking Agent, and BiomarC Restore Lumpectomy Fiducial Marker.
Carbon Medical Technologies operates through Carbon Medical Technologies In.